Structure of the BH3 Domains from the p53-Inducible BH3-Only Proteins Noxa and Puma in Complex with Mcl-1

Journal of Molecular Biology

Volumn 380, Issue 5, 2008, Pages 958-971

  Day, Catherine L ^a   Smits, Callum ^a   Fan, F Cindy ^b   Lee, Erinna F ^b   Fairlie, W Douglas ^b   Hinds, Mark G ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Bcl 2; BH3 only; enthalpy entropy compensation; intrinsically unstructured protein; Mcl 1

Indexed keywords

BH3 PROTEIN; PROTEIN BCL 2; PROTEIN MCL 1; PROTEIN NOXA; PROTEIN P53; PUMA PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING SITE; CALORIMETRY; COMPLEX FORMATION; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENTHALPY; ENTROPY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 45849104776     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2008.05.071     Document Type: Article

References (53)

1. Youle R.J., and Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 9 (2008) 47-59
2. Adams J.M., and Cory S. Bcl-2-regulated apoptosis: mechanism and therapeutic potential. Curr. Opin. Immunol. 19 (2007) 488-496
3. Huang D.C.S., and Strasser A. BH3-only proteins-essential initiators of apoptotic cell death. Cell 103 (2000) 839-842
4. Petros A.M., Olejniczak E.T., and Fesik S.W. Structural biology of the Bcl-2 family of proteins. Biochim. Biophys. Acta 1644 (2004) 83-94
5. Hinds M.G., and Day C.L. Regulation of apoptosis: uncovering the binding determinants. Curr. Opin. Struct. Biol. 15 (2005) 690-699
6. van Delft M.F., and Huang D.C. How the Bcl-2 family of proteins interact to regulate apoptosis. Cell Res. 16 (2006) 203-213
7. L-Bak peptide complex: recognition between regulators of apoptosis. Science 275 (1997) 983-986
8. Lanave C., Santamaria M., and Saccone C. Comparative genomics: the evolutionary history of the Bcl-2 family. Gene 333 (2004) 71-79
9. L/Bim fragment complex: implications for Bim function. Immunity 19 (2003) 341-352
10. Czabotar P.E., Lee E.F., van Delft M.F., Day C.L., Smith B.J., Huang D.C.S., et al. Structural insights into the degradation of Mcl-1 induced by BH3 domains. Proc. Natl. Acad. Sci. USA 104 (2007) 6217-6222
11. Chen L., Willis S.N., Wei A., Smith B.J., Fletcher J.I., Hinds M.G., et al. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol. Cell 17 (2005) 393-403
12. Craig R.W. MCL1 provides a window on the role of the BCL2 family in cell proliferation, differentiation and tumorigenesis. Leukemia 16 (2002) 444-454
13. Rinkenberger J.L., Horning S., Klocke B., Roth K., and Korsmeyer S.J. Mcl-1 deficiency results in peri-implantation embryonic lethality. Genes Dev. 14 (2000) 23-27
14. Opferman J.T., Letai A., Beard C., Sorcinelli M.D., Ong C.C., and Korsmeyer S.J. Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1. Nature 426 (2003) 671-676
15. Day C.L., Chen L., Richardson S.J., Harrison P.J., Huang D.C.S., and Hinds M.G. Solution structure of prosurvival Mcl-1 and characterization of its binding by proapoptotic BH3-only ligands. J. Biol. Chem. 280 (2005) 4738-4744
16. Fesik S.W. Promoting apoptosis as a strategy for cancer drug discovery. Nat. Rev. Cancer 5 (2005) 876-885
17. Hinds M.G., Smits C., Fredericks-Short R., Risk J.M., Bailey M., Huang D.C.S., and Day C.L. Bim, Bad and Bmf: intrinsically unstructured BH3-only proteins that undergo a localized conformational change upon binding to prosurvival Bcl-2 targets. Cell Death Differ. 14 (2007) 128-136
18. Ross P.D., and Subramanian S. Thermodynamics of protein association reactions: forces contributing to stability. Biochemistry 20 (1981) 3096-3102
19. Smits C., Czabotar P.E., Hinds M.G., and Day C.L. Structural plasticity underpins promiscuous binding of the pro-survival protein A1. Structure 16 (2008) 818-829
20. L-Beclin 1 peptide complex: Beclin 1 is a novel BH3-only protein. J. Biol. Chem. 282 (2007) 13123-13132
21. Sattler M., Schleucher J., and Griesinger C. Heteronuclear multidimensional NMR experiments for the structure determination of proteins in solution employing pulsed field gradients. Prog. Nucl. Magn. Reson. Spectrosc. 34 (1999) 93-158
22. Laskowski R.A., Rullmann J.A.C., MacArthur M.W., Kaptein R., and Thornton J.M. AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR 8 (1996) 477-486
23. Lu G.G. TOP: a new method for protein structure comparisons and similarity searches. J. Appl. Crystallogr. 33 (2000) 176-183
24. L, an inhibitor of programmed cell death. Nature 381 (1996) 335-341
25. Aurora R., and Rose G.D. Helix capping. Protein Sci. 7 (1998) 21-38
26. Gimpelev M., Forrest L.R., Murray D., and Honig B. Helical packing patterns in membrane and soluble proteins. Biophys. J. 87 (2004) 4075-4086
27. Zuiderweg E.R. Mapping protein-protein interactions in solution by NMR spectroscopy. Biochemistry 41 (2002) 1-7
28. Zhong Q., Gao W., Du F., and Wang X. Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis. Cell 121 (2005) 1085-1095
29. Wishart D.S., and Case D.A. Use of chemical shifts in macromolecular structure determination. Methods Enzymol. 338 (2001) 3-34
30. Williams D.H., Stephens E., O'Brien D.P., and Zhou M. Understanding noncovalent interactions: ligand binding energy and catalytic efficiency from ligand-induced reductions in motion within receptors and enzymes. Angew. Chem., Int. Ed. Engl. 43 (2004) 6596-6616
31. Williams D.H., O'Brien D.P., Sandercock A.M., and Stephens E. Order changes within receptor systems upon ligand binding: receptor tightening/oligomerisation and the interpretation of binding parameters. J. Mol. Biol. 340 (2004) 373-383
32. Leung D.H., Bergman R.G., and Raymond K.N. Enthalpy-entropy compensation reveals solvent reorganization as a driving force for supramolecular encapsulation in water. J. Am. Chem. Soc. 130 (2008) 2798-2805
33. Hatakeyama S., Hamasaki A., Negishi I., Loh D.Y., Sendo F., and Nakayama K. Multiple gene duplication and expression of mouse bcl-2-related genes, A1. Int. Immunol. 10 (1998) 631-637
34. Jones S., and Thornton J.M. Principles of protein-protein interactions. Proc. Natl. Acad. Sci. USA 93 (1996) 13-20
35. Rajamani D., Thiel S., Vajda S., and Camacho C.J. Anchor residues in protein-protein interactions. Proc. Natl Acad. Sci. USA. 101 (2004) 11287-11292
36. Hinds M.G., Lackmann M., Skea G.L., Harrison P.J., Huang D.C.S., and Day C.L. The structure of Bcl-w reveals a role for the C-terminal residues in modulating biological activity. EMBO J. 22 (2003) 1497-1507
37. L: implications for selectivity of antagonists of the Bcl-2 family. Cell Death Differ. 14 (2007) 1711-1713
38. Frederick K.K., Marlow M.S., Valentine K.G., and Wand A.J. Conformational entropy in molecular recognition by proteins. Nature 448 (2007) 325-329
39. Lee A.L., Kinnear S.A., and Wand A.J. Redistribution and loss of side chain entropy upon formation of a calmodulin-peptide complex. Nat. Struct. Biol. 7 (2000) 72-77
40. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
41. Oltersdorf T., Elmore S.W., Shoemaker A.R., Armstrong R.C., Augeri D.J., Belli B.A., et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435 (2005) 677-681
42. van Delft M.F., Wei A.H., Mason K.D., Vandenberg C.J., Chen L., Czabotar P.E., et al. The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. Cancer Cell 10 (2006) 389-399
43. Meszaros B., Tompa P., Simon I., and Dosztanyi Z. Molecular principles of the interactions of disordered proteins. J. Mol. Biol. 372 (2007) 549-561
44. Gunasekaran K., and Nussinov R. How different are structurally flexible and rigid binding sites? Sequence and structural features discriminating proteins that do and do not undergo conformational change upon ligand binding. J. Mol. Biol. 365 (2007) 257-273
45. Vacic V., Oldfield C.J., Mohan A., Radivojac P., Cortese M.S., Uversky V.N., and Dunker A.K. Characterization of molecular recognition features, MoRFs, and their binding partners. J. Proteome Res. 6 (2007) 2351-2366
46. Day C.L., Dupont C., Lackmann M., Vaux D.L., and Hinds M.G. Solution structure and mutagenesis of the caspase recruitment domain (CARD) from Apaf-1. Cell Death Differ. 6 (1999) 1125-1132
47. Bartels C., Xia T.H., Billeter M., Güntert P., and Wüthrich K. The program XEASY for computer-supported NMR spectral analysis of biological macromolecules. J. Biomol. NMR 6 (1995) 1-10
48. Cornilescu G., Delaglio F., and Bax A. Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J. Biomol. NMR 13 (1999) 289-302
49. Vuister G.W., and Bax A. Quantitative J correlation: a new approach for measuring homonuclear three-bond J(HNHα) coupling-constants in N-15-enriched proteins. J. Am. Chem. Soc. 115 (1993) 7772-7777
50. Güntert P. Automated NMR structure calculation with CYANA. Methods Mol. Biol. 278 (2004) 353-378
51. Schwieters C.D., Kuszewski J.J., and Clore G.M. Using Xplor-NIH for NMR molecular structure determination. Prog. Nucl. Magn. Reson. Spectrosc. 48 (2006) 47-62
52. Linge J.P., Williams M.A., Spronk C.A., Bonvin A.M., and Nilges M. Refinement of protein structures in explicit solvent. Proteins 50 (2003) 496-506
53. Koradi R., Billeter M., and Wüthrich K. MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graphics 14 (1996) 51-55